CAS No.74050-97-8,4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidyl decanoate Suppliers

Products Categories

Pharmaceutical (14)
Others (13)
Organic Chemicals (5)

Basic Information

Molecular Structure:
CAS No.:	74050-97-8
Name:	4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidyl decanoate

Formula:	C₃₁H₄₁ClFNO₃
Molecular Weight:	530.123
Synonyms:	Haldoldecanoate;Halomonth;KD 136;KD 16;Neoperidole;R13762;
EINECS:	277-679-7
Density:	1.14 g/cm³
Melting Point:	326.1 °C
Boiling Point:	615.5 °C at 760 mmHg
Flash Point:	326.1°C
PSA:	46.61000
LogP:	8.05510

Total:32 Page 1 of 1 1

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 74050-97-8

Chemistry

Molecular structure of Haloperidol decanoate (CAS NO.74050-97-8) is:

Product Name: Haloperidol decanoate
CAS Registry Number: 74050-97-8
IUPAC Name: [4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl]decanoate
Molecular Weight: 530.113543 [g/mol]
Molecular Formula: C₃₁H₄₁ClFNO₃
XLogP3: 7.9
H-Bond Donor: 0
H-Bond Acceptor: 5
EINECS: 277-679-7
Surface Tension: 46.6 dyne/cm
Density: 1.14 g/cm³
Flash Point: 326.1 °C
Enthalpy of Vaporization: 91.32 kJ/mol
Boiling Point: 615.5 °C at 760 mmHg
Vapour Pressure: 4.38E-15 mmHg at 25 °C
Product Categories: Organics

Toxicity Data With Reference

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	LD50	intramuscular	> 1gm/kg (1000mg/kg)	SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985.
mouse	LD50	intramuscular	> 3500mg/kg (3500mg/kg)	SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985.
mouse	LD50	intraperitoneal	288mg/kg (288mg/kg)	SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"	Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985.
mouse	LD50	oral	739mg/kg (739mg/kg)	SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985.
mouse	LD50	subcutaneous	1990mg/kg (1990mg/kg)	SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985.
rat	LD50	intramuscular	> 1525mg/kg (1525mg/kg)	SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985.
rat	LD50	intraperitoneal	328mg/kg (328mg/kg)	SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985.
rat	LD50	oral	1717mg/kg (1717mg/kg)	SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985.
rat	LD50	subcutaneous	780mg/kg (780mg/kg)	SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 6731, 1985.
women	TDLo	intravenous	11600ug/kg/4D (11.6mg/kg)	CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE CARDIAC: CHANGE IN RATE	Annals of Internal Medicine. Vol. 119, Pg. 391, 1993.

Safety Profile

Poison by intraperitoneal route. Moderately toxic by ingestion, subcutaneous, and intramuscular routes. An experimental teratogen. Other experimental reproductive effects. Human systemic effects: arrhythmias, EKG changes, heart rate changes. When heated to decomposition it emits toxic fumes of F−, Cl−, and NOx.
RIDADR: 3249
HazardClass: 6.1(b)
PackingGroup: III

Specification

Haloperidol decanoate , its cas register number is 74050-97-8. It also can be called Haloperidol decanoate [USAN:BAN:JAN] ; Decanoic acid, 4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl ester ; Decanoic acid, ester with 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone ; Depot haloperidol ; Haldol ; Haldol decanoas ; Haldol decanoate ; Halomonth ; Haloperidol decanoate ; Haloperidol depot .